Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003
Clinical trial NCT01856309 · COMPLETED
Trial details
- NCT number
- NCT01856309
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-07
- Primary completion
- 2018-04-30
- Enrollment
- 1820
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.